Ras-related C3 botulinum toxin substrate one gene (RAC1) has two isoforms that change the sequence of the protein (RAC1 and RAC1B), with differential risks to cancer progression (Jordan et al., 1999; Melzer et al., 2019). The gene discussed is RAC1; the disease is cancer.